People | April 15, 2026
Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets
In his new role, Karthik will lead human capital strategy and HR operations across these regions
In his new role, Karthik will lead human capital strategy and HR operations across these regions
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Healthy growth in domestic and emerging markets is expected to support revenue growth in the next few quarters
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
Subscribe To Our Newsletter & Stay Updated
